Abstract:Objective The incidence of acute pulmonary injury occurred after cardiopulmonary bypass for fallot tetrad has been high. The severity of pulmonary ischemia-reperfusion has been found to be reduced with ulinastatin (UTI) in the animal models and clinical practice. We evaluated the effect of pulmonary artery perfusion with a hypothermic protective solution containing ulinastatin on the inflammatory response in the lung during cardiopulmonary bypass. Methods 30 children with tetralogy of Fallot (TOF) were randomly assigned into control group and protective group, 15 cases in each group. Patients would be excluded if they had signs of infections, such as the white blood cell count was over 12000 per microliter, the temperature was above 38 centi-degree and the c-reaction protein was more than 8 mg/L. Operation with routine approaches was performed in the control group and the pulmonary artery was infused with 4℃ protective solution in the protective group while the heart stoped beating. Plasma tumor necrosis factor α (TNF-α) 、CD11b and Myeloperoxidase (MPO) were measured intraoperatively and postoperatively. Blood gas、pulmonary function and clinic index of the patients were also monitored. Results The level of TNF-α was lower in the protective group as compared with that in the control group immediately and 3 hours after closing the sternum [(11.15±2.47) pg/ml vs. (14.21 ±5.55) pg/ml, P<0.05; (12.01 ±2.69) pg/ml vs. (15.94 ±4.86)pg/ml,P <0.01]. The MFI of CD11b was lower in the protective group as compared with that in the control group at 3 and 6 hoursafter closing the sternum (126.23±36.05 vs. 156.98±48.34, P<0.05; 137.27±38.85 vs. 173.27±67.43, P<0.05). The level of MPO was lower in protective group as compared with that in the control group at 3 hours, 6 hours and 24hours after closing the sternum [(156.52±17.57)U/L vs.(178.45±35.68)U/L, P<0.05; (178.28±23.63) U/L vs.(224.66±49.66)U/L, P<0.01;(130.52±57.50)U/L vs. (96.50±14.49)U/L, P<0.05]. The duration of mechanical ventilation was significantly shorter in the protective group than that in the control group (17.60±6.39 vs. 23.70±8.51,P<0.05). Alveolar-arterial oxygen pressure difference (A-aDO2, calculated as [FiO2×713-5/4×PaCO2]-PaO2) in the protective group was less than that in the control group at 3 and 6 hours after closing the sternum [(120.92±33.08)mm Hg vs. (145.52±39.38)mmHg, P<0.05;(74.76±40.16)mm Hg vs. (112.50±44.16)mmHg, P<0.01]. Dynamic compliance (Cdyn) in protective group was lower than that in control group at 3 and 6 hours after closing the sternum [(0.59±0.11)ml·cmH2O-1·kg-1 vs. (0.46±0.17)ml·cmH2O-1·kg-1, P<0.05;(0.67±0.09)ml·cmH2O-1·kg-1vs. (0.53±0.18)ml·cmH2O-1·kg-1,P<0.05). Conclusion Perfusion with hypothermic protective solution containing UTI to the pulmonary artery during cardiopulmonary bypass may reduce the inflammatory responses substantially in the lung after bypass and had a role in the lung protection.

The effect of atopy on inflammatory response to cardiopulmonary bypass in infant

The effect of cardiopulmonary bypass on the activation of peripheral T lymphocytes in children under open - heart operation

Protective Effects of Acupuncture in Cardiopulmonary Bypass-Induced Lung Injury in Rats

Variations and Significance of IL-8 in the Bronchoalveolar Lavage Fluid in the Perioperative Period of Cardiopulmonary Bypass Operation on Children

Changes in transforming growth factor-beta mRNA expressionin the lung in a dog model of cardiopulmonary bypass-induced acute lung injury

Effects of Pulmonary Protective Solution Involved Ulinastatin on Lung Function after Cardioopulmonary Bypass

[Effect of Cardiopulmonary Bypass on CD11/CD18 Expression of Neutrophils in Children Undergoing Cardiac Surgery].

The protective role of hypothermic protective solution during surgey for the tetralogy of Fallot

Detection of Intercellular Adhesion Molecule-1 during Pediatric Cardiopulmonary Bypass

Effect of Open Heart Surgery with Cardiopulmonary Bypass on Peripheral Blood Lymphocyte Apoptosis in Children

Studying the Association of Plasma S100a12 and Noninfectious Pulmonary Complication in Infants and Young Children Following Cardiopulmonary Bypass

Studying the association of plasma S100A12 and noninfectious pulmonary complication in infants and young children following cardiopulmonary bypass (HUM1P.305)

Effects of Cardiopulmonary Bypass on Plasma Levels of Procalcitonin and Cytokines

Effects of Combination of Ultrafiltration of Routine and Improved Method on the Expression of Cytokines and Cell Adhesion Molecules in Perioperative Period of Cardiopulmonary Bypass in Children

Inflammatory cytokines in infants after cardiopulmonary bypass

The effect of cardiopulmonary bypass on monocyte HLA-DR expression

The Effect of Cardiopulmonary Bypass Duration on Renal Injury after Congenital Heart Surgery in Infants and Young Children.

Cardiopulmonary bypass parameters and hemostatic response to cardiopulmonary bypass in infants versus children

Effects of Circuit Residual Volume Salvage Reinfusion on the Postoperative Clinical Outcome for Pediatric Patients Undergoing Cardiac Surgery

Questions on life satisfaction (FLZM) in inflammatory bowel disease

Integrated Analysis of Tracheobronchial Fluid from Before and after Cardiopulmonary Bypass Reveals Activation of the Integrated Stress Response and Altered Pulmonary Microvascular Permeability.